MRO
46
3
LNC
45
-4
LRCX
46
-2
MMM
42
5
BLK
70
-2
ABT
57
-5
EMC
53
-3
PAYX
57
-2
IVZ
49
-3
AON
60
2
DLTR
40
4
OXY
55
6
R
77
2
LB
63
-4
DOW
30
2
EW
32
3
SE
60
-5
GPC
40
2
NKE
33
2
JCI
61
-2
MRO
46
3
LNC
45
-4
LRCX
46
-2
MMM
42
5
BLK
70
-2
ABT
57
-5
EMC
53
-3
PAYX
57
-2
IVZ
49
-3
AON
60
2
DLTR
40
4
OXY
55
6
R
77
2
LB
63
-4
DOW
30
2
EW
32
3
SE
60
-5
GPC
40
2
NKE
33
2
JCI
61
-2
Financhill
Back

Genmab AS Vs. Ascendis Pharma AS Industry Stock Comparison

Sell
32

GMAB
Genmab AS

Last Price:
21.21
Seasonality Move:
3.28%
Sell
28

ASND
Ascendis Pharma AS

Last Price:
124.27
Seasonality Move:
15.69%
Sell
32
Genmab AS (GMAB) is a Sell

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GMAB] share price is $21.67. The Score for GMAB is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $126.03. The Score for ASND is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GMAB Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $21.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing selling pressure, which indicates risk of future bearish movement.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $126.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.

GMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.41 Sell
Relative Strength Index (14 RSI): 32.32 Sell
Chaikin Money Flow: -1905875 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.44 - 23.32) Sell
Bollinger Bands (100): (23.53 - 27.49) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.86 Sell
Relative Strength Index (14 RSI): 44.69 Sell
Chaikin Money Flow: -372056 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (125.55 - 129.91) Sell
Bollinger Bands (100): (125.23 - 141.83) Sell

GMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.67 Sell
20-day SMA: 22.76 Sell
50-day SMA: 24.08 Sell
200-day SMA: 27.13 Sell
8-day EMA: 22.56 Sell
20-day EMA: 22.87 Sell
50-day EMA: 23.9 Sell
200-day EMA: 27.12 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 127.05 Sell
20-day SMA: 127.45 Sell
50-day SMA: 131.9 Sell
200-day SMA: 137.23 Sell
8-day EMA: 126.87 Sell
20-day EMA: 128.19 Sell
50-day EMA: 131.06 Sell
200-day EMA: 130.63 Sell

Genmab AS Earnings Growth & GMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.29 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $4.28 per share.

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):